Shelter Pharma Ltd
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including
food supplements for animals[1]
- Market Cap ₹ 49.7 Cr.
- Current Price ₹ 43.0
- High / Low ₹ 69.7 / 35.7
- Stock P/E 6.87
- Book Value ₹ 37.0
- Dividend Yield 0.81 %
- ROCE 24.5 %
- ROE 18.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.16 times its book value
- Company has delivered good profit growth of 146% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.4%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
28.09 | 29.95 | 30.07 | 22.48 | 30.06 | 36.15 | 39.93 | 50.64 | |
27.94 | 30.65 | 29.83 | 22.29 | 27.01 | 28.00 | 31.14 | 40.57 | |
Operating Profit | 0.15 | -0.70 | 0.24 | 0.19 | 3.05 | 8.15 | 8.79 | 10.07 |
OPM % | 0.53% | -2.34% | 0.80% | 0.85% | 10.15% | 22.54% | 22.01% | 19.89% |
0.00 | 0.83 | 0.01 | 0.01 | 0.00 | -0.97 | 0.00 | 0.01 | |
Interest | 0.00 | 0.00 | 0.01 | 0.02 | 0.08 | 0.03 | 0.26 | 0.13 |
Depreciation | 0.10 | 0.07 | 0.13 | 0.12 | 0.17 | 0.16 | 0.25 | 0.27 |
Profit before tax | 0.05 | 0.06 | 0.11 | 0.06 | 2.80 | 6.99 | 8.28 | 9.68 |
Tax % | 20.00% | 16.67% | 27.27% | 33.33% | 26.79% | 25.46% | 25.12% | 25.21% |
0.05 | 0.05 | 0.08 | 0.04 | 2.06 | 5.21 | 6.20 | 7.24 | |
EPS in Rs | 1.10 | 1.10 | 1.76 | 0.83 | 42.56 | 6.73 | 5.36 | 6.26 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 19% |
TTM: | 27% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 146% |
3 Years: | 52% |
TTM: | 17% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 24% |
3 Years: | 25% |
Last Year: | 18% |
Balance Sheet
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 0.45 | 0.45 | 0.45 | 0.48 | 0.48 | 7.74 | 11.56 | 11.56 |
Reserves | 7.31 | 7.32 | 6.53 | 6.63 | 8.32 | 6.81 | 24.26 | 31.16 |
2.07 | 0.11 | 0.24 | 0.00 | 0.13 | 1.78 | 0.58 | 1.04 | |
1.73 | 3.76 | 3.41 | 3.09 | 3.91 | 5.12 | 1.51 | 4.58 | |
Total Liabilities | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 48.34 |
2.61 | 2.71 | 1.77 | 1.57 | 1.45 | 2.52 | 4.26 | 6.64 | |
CWIP | 0.14 | 0.11 | 0.00 | 0.00 | 0.55 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.68 | 0.68 | 0.68 | 0.00 | 0.00 | 0.00 |
8.81 | 8.82 | 8.18 | 7.95 | 10.16 | 18.93 | 33.65 | 41.70 | |
Total Assets | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 48.34 |
Cash Flows
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
0.00 | -0.27 | -0.28 | 0.52 | 0.00 | -1.96 | 5.48 | ||
0.00 | 0.29 | 0.03 | -0.85 | 0.11 | -4.43 | -7.13 | ||
0.00 | 0.00 | 0.48 | 0.06 | 0.21 | 11.01 | 0.03 | ||
Net Cash Flow | 0.00 | 0.02 | 0.23 | -0.27 | 0.33 | 4.61 | -1.62 |
Ratios
Figures in Rs. Crores
Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 12.99 | 14.14 | 7.40 | 12.34 | 19.55 | 82.69 | 80.90 | 68.26 |
Inventory Days | 61.39 | 49.67 | 55.59 | 69.41 | 80.06 | 110.68 | 125.33 | 127.15 |
Days Payable | 2.49 | 2.16 | 3.35 | 5.35 | 4.52 | 6.54 | 8.96 | 12.32 |
Cash Conversion Cycle | 71.89 | 61.65 | 59.64 | 76.40 | 95.09 | 186.84 | 197.26 | 183.09 |
Working Capital Days | 91.35 | 59.59 | 54.14 | 74.85 | 71.64 | 121.57 | 212.07 | 181.85 |
ROCE % | 0.68% | 1.12% | 35.91% | 63.26% | 32.39% | 24.48% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
8 Sep - Newspaper Publication Regrading 18th AGM to be held on 30th September, 2025
- Notice Of 18Th Annual General Meeting 6 Sep
- Reg. 34 (1) Annual Report. 6 Sep
-
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
2 Sep - Board set 18th AGM on 30 Sep 2025; recommended final dividend 3.5% (₹0.35); appointed Alvi & Associates as statutory auditors.
-
Approved Tuesday, 23Rd September , 2025 As The Cut-Off Date As For The Purpose Of E-Voting And Dividend Entitlement. Dividend Shall Be Payable To Equity Shareholder; Whose Names Stand Registered On The Company'S Register Of
Members As Beneficial Owners As At The End Of Business Hours On Tuesday, 23Rd September, 2025 As Per The List Provided By National Securities Depository Limited And Central Depository Services (India) Limited In Respect Of The Shares Held In The Electronic Form
2 Sep - Board recommended final dividend 3.5% (Rs.0.35/share); record date 23 Sep 2025, subject to AGM approval.
Business Overview:[1]
SPL is a GMP & HACCP certified and ISO 9001:2015 certified manufacturer and seller of a range of herbal Ayurvedic medicines in India for humans and food supplements for animals